A. Dagović

发表

Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma. A phase II study.

B. Jeremic, Y. Shibamoto, D. Grujičić, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Interrogating and Quantifying In Vitro Cancer Drug Pharmacodynamics via Agent-Based and Bayesian Monte Carlo Modelling

A. Dagović, M. Zivanovic, V. Vavourakis, 2022, Pharmaceutics.

Interfraction Interval in Patients With Stage III Non-Small-Cell Lung Cancer Treated With Hyperfractionated Radiation Therapy With or Without Concurrent Chemotherapy: Final Results in 536 Patients

B. Jeremic, B. Miličić, A. Dagović, 2004, American journal of clinical oncology.

Stage III Non–Small-Cell Lung Cancer Treated With High-Dose Hyperfractionated Radiation Therapy and Concurrent Low-Dose Daily Chemotherapy With or Without Weekend Chemotherapy: Retrospective Analysis of 301 Patients

B. Jeremic, B. Miličić, A. Dagović, 2004, American journal of clinical oncology.

Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC): long-term results of a phase II study.

B. Jeremic, Y. Shibamoto, B. Miličić, 1998, International journal of radiation oncology, biology, physics.

Radiation therapy remains the key cost driver of oncology inpatient treatment

A. Dagović, M. Jakovljevic, A. Žugić, 2015, Journal of medical economics.

Five-year survival and costs of care in metastatic colorectal cancer: conventional versus monoclonal antibody-based treatment protocols

A. Dagović, M. Jakovljevic, N. Rančić, 2015, Expert review of anticancer therapy.

Efficacy and safety of bevacizumab in combination with oxaliplatin, irinotecan and fluoropyrimidine-based therapy in advanced colorectal cancer

A. Dagović, S. Jezdic, B. Kukic, 2007 .

Pretreatment prognostic factors in patients with early-stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone.

B. Jeremic, B. Miličić, A. Dagović, 2006, International journal of radiation oncology, biology, physics.

Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone.

B. Jeremic, Y. Shibamoto, B. Miličić, 2003, Lung cancer.

Second C ancers O ccurring i n P atients W ith E arly S tage Non-Small-Cell L ung C ancer T reated W ith C hest Radiation T herapy A lone

B. Jeremic, Y. Shibamoto, N. Nikolić, 2013 .

Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study.

B. Jeremic, Y. Shibamoto, B. Miličić, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Economics of cancer related medical care: Worldwide estimates and available domestic evidence

A. Dagović, M. Jakovljevic, A. Radovanovic, 2011 .

External beam radiation therapy alone for loco-regional recurrence of non-small-cell lung cancer after complete resection.

B. Jeremic, Y. Shibamoto, B. Miličić, 1999, Lung cancer.

Appearance of ductal breast and colon carcinoma with gastrointestinal stromal tumor (GIST) in a female patient: an extremely rare case.

A. Dagović, S. Mitrovic, V. Jurišić, 2018, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.

B. Jeremic, Y. Shibamoto, B. Miličić, 2001, International journal of radiation oncology, biology, physics.

Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma.

A. Dagović, M. Jakovljevic, F. Gutzwiller, 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer.

B. Jeremic, Y. Shibamoto, B. Miličić, 1999, International journal of radiation oncology, biology, physics.

Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.

B. Jeremic, B. Miličić, A. Dagović, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prolonged oral versus high-dose intravenous etoposide in combination with carboplatin for stage IV non-small-cell lung cancer (NSCLC): a randomized trial.

B. Jeremic, Y. Shibamoto, B. Miličić, 1999, Lung cancer.

Does the Expression of Vascular Endothelial Growth Factor (VEGF) and Bcl-2 Have a Prognostic Significance in Advanced Non-Small Cell Lung Cancer?

A. Dagović, S. Mitrovic, R. Vojinovic, 2023, Healthcare.

Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy

B. Jeremic, B. Miličić, N. Nikolić, 2003, Journal of Cancer Research and Clinical Oncology.

Short-term chemotherapy and palliative radiotherapy for elderly patients with stage IV non-small cell lung cancer: a phase II study.

B. Jeremic, Y. Shibamoto, B. Miličić, 1999, Lung cancer.

Combined Treatment Modality for Anaplastic Oligodendroglioma: A Phase II Study

B. Jeremic, Y. Shibamoto, D. Grujičić, 1999, Journal of Neuro-Oncology.

Hyperfractionated Radiation Therapy With or Without Concurrent Low-Dose Daily Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Prospective Randomized Trial

B. Jeremic, Y. Shibamoto, B. Miličić, 2000 .

Clinical Prognostic Factors in Patients With Malignant Glioma Treated With Combined Modality Approach

B. Jeremic, D. Grujičić, B. Miličić, 2004, American journal of clinical oncology.

Concurrent Accelerated Hyperfractionated Radiation Therapy and Carboplatin/etoposide in Patients With Malignant Glioma: Long-term break Results of A Phase II Study

B. Jeremic, Y. Shibamoto, D. Grujičić, 2004, Journal of Neuro-Oncology.

Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.

B. Jeremic, D. Grujičić, B. Miličić, 2004, International journal of radiation oncology, biology, physics.

Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study.

B. Jeremic, Y. Shibamoto, D. Grujičić, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Short-course Radiotherapy in Elderly and Frail Patients with Glioblastoma Multiforme. A Phase II Study

B. Jeremic, Y. Shibamoto, D. Grujičić, 1999, Journal of Neuro-Oncology.

Hospital oncology costs among the cohort of elderly in an aging South-Eastern European nation

A. Dagović, M. Jakovljevic, M. Folic, 2015 .

Macroeconomic Policy Impact On Oncology-Related Public Expenditure In An Emerging European Market – Signs Of Early Recovery

A. Dagović, A. Zugic, M. Jakovljevic, 2015 .

Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone.

B. Jeremic, Y. Shibamoto, N. Nikolić, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach

B. Jeremic, D. Grujičić, B. Miličić, 2003, Journal of Cancer Research and Clinical Oncology.

Role o f R adiation T herapy i n t he C ombined-Modalit y Treatment o f P atients W ith E xtensive D isease Small-Cell L ung C ancer: A R andomized S tudy

B. Jeremic, Y. Shibamoto, B. Miličić, 1999 .

No thoracic radiation myelitis after spinal cord dose > or = 50.4 Gy using 1.2. Gy b.i.d. fractionation in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy.

B. Jeremic, Y. Shibamoto, B. Miličić, 2002, Lung cancer.

Resource use and costs of newly diagnosed cancer initial medical care

A. Dagović, M. Jakovljevic, F. Gutzwiller, 2015 .

Hyperfractionated radiotherapy (Hfx RT) with or without concurrent low-dose daily cisplatin (CDDP) in locally advanced unresectable squamous cell carcinoma of the head and neck (SCC H&N). A prospective randomized trial

B. Jeremic, Y. Shibamoto, B. Miličić, 1999 .

Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma: a 10-year update of a phase II study.

B. Jeremic, B. Miličić, A. Dagović, 2003, International journal of radiation oncology, biology, physics.

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial.

B. Jeremic, Y. Shibamoto, N. Nikolić, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trends and Patterns of Disparities in Oral Cavity and Pharyngeal Cancer in Serbia: Prevalence and Economic Consequences in a Transitional Country

A. Dagović, T. Kanjevac, D. Brajkovic, 2017, Front. Pharmacol..

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial.

B. Jeremic, Y. Shibamoto, B. Miličić, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary Small Cell Carcinoma Of Lung With Metachronous Breast Metastasis

A. Dagović, S. Mitrovic, J. Nešić, 2017 .

Efficacy and safety of bevacizumab in combination with oxaliplatin, irinotecan and fluoropyrimidine-based therapy in advanced colorectal cancer

A. Dagović, S. Jezdic, B. Kukic, 2007 .